Clinical trial
Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing…
NCT00155844 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00155844 |
|---|---|
| Title | Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier" |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia |
| Enrollment | 30 |
| Start date | Feb 1, 2003 |
| Completion | Jul 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: